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Abstract—Two optimized strategies were successfully established 
to develop biomolecule-based magnetic nanoassemblies. 
Streptavidin-coated and amine-coated magnetic nanoparticles were 
chosen as model scaffolds onto which double-stranded DNA and 
human immunoglobulin G were specifically conjugated in succession, 
using biotin-streptavidin interaction or covalent cross-linkers. The 
success of this study opens the prospect of developing selective and 
sensitive nanoparticle-based structures for diagnostics or drug 
delivery. 
 
Keywords—Antibody, DNA, linker, magnetic nanoparticles, 
streptavidin 
I. INTRODUCTION 
REAT efforts have been invested to develop high 
throughput proteomics methods for detection and analysis 
of specific proteins, which could greatly benefit in the 
diagnosis and treatments of multiple diseases [1]. Antibodies, 
due to their large diversity and specific binding properties, have 
been widely utilized for target protein identification and 
characterization [2, 3]. Some technologies, especially those for 
multiplexed protein analysis; rely on DNA conjugation to the 
antibody, either as universal linkers [4, 5] or as functional bar 
code [6, 7]. In addition, DNA conjugation can significantly 
reduce non-specific binding, thus improving the sensitivity of 
certain bioassays [8, 9]. 
DNA-antibody conjugation could be achieved either by non 
covalent coupling or covalent coupling chemistry. For 
example, the extraordinary affinity of biotin and avidin 
(Ka=1015 M-1) has been widely utilized in biomolecule 
conjugation system. Biotin is a small molecule (244 Da), which 
could be conjugated to the target antibody without significant 
alteration of antibody’s activity. In addition, DNA synthesized 
with functional groups can also be covalently conjugated on the 
surface of target protein using various conjugation chemistries. 
For example, N-hydroxysuccinimide (NHS) is one of the most 
frequently used cross linking groups in the conjugation of 
amine groups in proteins, which are present on most antibodies 
due to the abundance of lysine side chain ε-amine and 
N-terminal α-amine. Beyond NHS, sulfhydryl or aldehyde 
groups can also be generated by reducing disulfide bonds in the 
hinge region or by oxidizing carbohydrate residues of antibody, 
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respectively. Free sulfhydryl group or active aldehyde group 
can then react with maleimide or amine group on target 
molecule to form stable thioether bond or amide bond, 
respectively. A number of these cross linking chemistries are 
commercially available. For example, companies such as 
SoluLink, Merck, Abgent, etc., utilize hydrazine and aldehyde 
as cross-linkers in conjugation reactions and they offer more 
promises in tailoring target-specific bio-conjugates.   
As versatile molecular tools, DNA-antibody conjugates 
have been widely applied in planar-based [10] or beads-based 
assays [11] for the detection of DNA, proteins or cell sorting. 
Among these methods, nanoparticles (NPs), typically ranging 
in size from 1 nm to 1 micron, have drawn considerable 
attention as an attractive structural scaffold with wide 
functional diversity [12, 13]. When their surface is modified 
with biomolecules, these biomolecule-functionalized NPs can 
offer unique advantages for developing selective and highly 
sensitive nanoparticle-based diagnostics and therapeutics. 
Thus, biomolecule modified NPs have been widely used in the 
fields of biotechnology and biomedicine, as selective and 
ultra-sensitive probes [14-16].  
In this work, two optimized strategies were successfully 
established to tailor biomolecule-functionalized magnetic NPs 
for inclusion into complex nanostructures. Both streptavidin 
(SA)-coated and amine-coated magnetic NPs were used as 
scaffolds onto which double stranded DNA (dsDNA) and 
human immunoglobulin G (IgG) were conjugated in sequence 
via biotin-SA linkages and commercially available covalent 
cross-linkers. 
II. MATERIALS AND METHODS 
A. Reagents 
Amine- and SA-coated magnetic TurboBeads® (ø=50nm, 
TurboBeads Ltd., Zurich), human IgG (Sigma-Aldrich, 
Australia), Sulfo-Succinimidyl 4-formylbenzoate 
(Sulfo-S-4FB, Solulink, USA), Sulfo-succinimidyl 
6-hydrazinonicotinate acetone hydrazone, (Sulfo-S-HyNic, 
Solulink, USA), Sulfo-NHS-LC-Biotin (Thermo Scientific, 
Australia). 6x Loading Dye (Promega, USA), 100bp DNA 
Ladder (Promega, USA), BenchMark Ladder (Invitrogen, 
USA), SYBR Safe DNA Gel Stain (Invitrogen, USA), NuPage 
LDS Sample Buffer (Invitrogen, USA), SYBR Green DNA Gel 
Stain (Invitrogen, USA), SYPRO Ruby Protein Gel Stain 
(Invitrogen, USA), Tris Acetate SDS Buffer (Invitrogen, 
USA), MES buffer (Invitrogen, USA) . 
ssDNA with either biotin (Bio-) or amine functional group 
was synthesized by  IDT, USA. Nucleotide sequences were as 
following:  
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Bio-AAAC: /5Biosg/AAA CAA ACA AAC AAA CAA 
ACA AAC AAA CAA ACA AAC AAA CAA ACA AAC 
AAA CAA ACA AAC AAA CAA ACA AAC AAA CAA 
ACA AAC AAA CAA ACA AAC AAA CAA ACA AAC 
AAA CAA ACA AAC AAA CAA ACA AAC AAA CAA 
ACA AAC AAA CAA ACA AAC AAA CAA ACA AAC 
AAA CAA ACA AAC AAA CAA ACA AAC AAA CAA AC 
Bio-GTTT: /5Biosg/GTT TGT TTG TTT GTT TGT TTG 
TTT GTT TGT TTG TTT GTT TGT TTG TTT GTT TGT 
TTG TTT GTT TGT TTG TTT GTT TGT TTG TTT GTT 
TGT TTG TTT GTT TGT TTG TTT GTT TGT TTG TTT 
GTT TGT TTG TTT GTT TGT TTG TTT GTT TGT TTG 
TTT GTT TGT TTG TTT GTT TGT TTG TTT GTT TGT 
TTG TTT GTT TGT TT 
Amine-GTTT: /5AmMC6/GTT TGT TTG TTT GTT TGT 
TTG TTT GTT TGT TTG TTT GTT TGT TTG TTT GTT 
TGT TTG TTT GTT TGT TTG TTT GTT TGT TTG TTT 
GTT TGT TTG TTT GTT TGT TTG TTT GTT TGT TTG 
TTT GTT TGT TTG TTT GTT TGT TTG TTT GTT TGT 
TTG TTT GTT TGT TTG TTT GTT TGT TTG TTT GTT 
TGT TTG TTT GTT TGT TT 
Bio-CL-Rev2: /5Biosg/GCG GCA CTA CGG CAA TAA 
TCC 
B. Modification of Amine-coated TurboBeads® with 
Sulfo-S-HyNic 
The process of DNA and antibody conjugation on 
amine-coated NPs was shown in Fig. 1. Briefly, amine-coated 
TurboBeads® solution was vortexed for 1min and 100 µL of the 
well-suspended colloid was taken for further manipulation.  
NPs were separated from supernatant using a magnet and 
re-suspended in 500 µL of 5x SSC (0.75M NaCl, 75mM 
sodium citrate, Sigma-Aldrich, Australia). 10 µL of 20 mg/mL 
S-Hynic dissolved in Milli Q water was added into NPs 
solution and incubated in a sonicating water bath (Unisonics, 
Australia) for 1 h at room temperature with shaking at regular 
intervals (to ensure the NPs were always in suspension). After 
modification, the NPs were washed 3 times with 5x SSC via 
magnetic separation and eventually re-suspended with 500 µL 
of 5x SSC.   
C. Modification of Amine-GTTT with Sulfo-S-4FB 
40 mole equivalents of 20 mg/mL Sulfo-S-4FB was added to 
Amine-GTTT and mixed well in Milli Q water. The mixture 
was incubated for 2 hours at room temperature. 
D. 4FB-modified DNA Precipitation 
After 4FB modification, 20 µL DNA was purified by sodium 
acetate-ethanol precipitation procedure. Briefly, 10% (v/v) of 
saturated sodium acetate (pH 6.0) and 75% (v/v) of 100% 
ethanol (ice cold) were added into 4FB-modified ssDNA 
solution following by vortexing and centrifugation at 20,000 
rpm for 10min. The supernatant was discarded and 70% 
Ethanol (ice cold) was added. The mixture was centrifuged at 
20,000 rpm for 10 min again. The pellet obtained was air dried 
and was suspended in 20 µL Conjugation Buffer (100mM 
sodium phosphate, 50mM Sodium Chloride, pH 6.0). The 
concentration of DNA was determined using the NanoDrop 
1000 Spectrometer (Thermo Scientific, USA). 
E. DNA Conjugation on Amine-coated TurboBeads® 
20 µL of 50 µM of 4FB-modified ssDNA were added into 
500 µL NPs solution (2x molar access). The mixture was 
incubated in a water-bath sonicator for overnight. NPs were 
then washed with 5x SSC by using magnet and supernatant was 
discarded. NPs were re-suspended in 500 µL of 5x SSC. 8 µL 
of 100 µM of Bio-AAAC was then added into 500 µL NPs 
solution. The mixture was incubated in water-bath sonicator for 
1 h with shaking at regular intervals to ensure NPs were in 
suspension, followed by additional three washes with 5x SSC. 
The NPs were eventually re-suspended in 500 µL of 5x SSC, 
and 100 µL of well-suspended NPs mixture was taken out for 
DNA conjugation analysis. 
 
Fig. 1 The schematic diagram of DNA-antibody conjugation on 
amine-coated magnetic NPs. 
 
F. DNA Conjugation on SA-coated TurboBeads® 
 The process of DNA and antibody conjugation on 
SA-coated NPs was shown in Fig. 2. Briefly, SA-coated 
TurboBeads® solution was vortexed for 1min and 100 µL of the 
well-suspended colloid was taken for further processing. NPs 
were separated from supernatant using magnet and 
re-suspended in 500 µL of 5x SSC, and 8 µL of 100 µM of 
Bio-AAAC were added into 500 µL NPs suspension (2x molar 
access). The mixture was incubated in water-bath sonicator for 
1 h at room temperature. After incubation, NPs were washed 
with 5x SSC by using magnet to recover the NPs, while the 
supernatant was discarded. NPs were then re-suspended in 500 
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µL of 5x SSC. 5 µL of 150 µM Bio-CL-Rev2 was added into 
500 µL NPs mixture in order to block unoccupied SA binding 
sites, After 1 h incubation in water bath sonicator and three 
washes with 5x SSC, the NPs were re-suspended with 500 µL 
of 5x SSC. 8 µL of 100 µM of Bio-GTTT, as complementary 
DNA, was then added and the mixture was incubated in 
water-bath sonicator for 1 h, followed by three washes with 5x 
SSC. The NPs were eventually re-suspended in 500 µL of 5x 
SSC and 100 µL of the well-suspended NPs mixture was taken 
out for DNA conjugation analysis. 
 
 
Fig. 2 The schematic diagram of DNA-antibody conjugation on 
amine-coated magnetic NPs. 
 
G. SA Conjugation on dsDNA Modified TurboBeads® 
65 µL of 1 µg/µL SA was added into 400 µL NPs solution 
(molar access of protein/DNA is 2:1 assuming 100% DNA was 
attached on NPs). The mixture was then incubated in water bath 
sonicator for 1 h, followed by wash with TE buffer (10 mM 
Tris-Cl, pH 7.5. 1 mM EDTA). NPs were re-suspended in 400 
µL of TE buffer after 3 times wash. 10 µL of supernatant and 
10 µL of well-suspended NPs mixture were taken for SA 
analysis, respectively. 
H. Biotinylation of IgG 
 1 mg sulfo-NHS-LC-Biotin was dissolved in 180 µL of 
deionized water to a final concentration of 10 mM. 28 µL of 
fresh prepared reagent added into 500 µL of 4.2 µg/ µL IgG 
solution. The mixture was mixed and incubated on ice for two 
hours. After incubation, biotinylated IgG was purified using 
Zebra Spin column (MWCO 50 kDa, Thermo Scientific, USA). 
The degree of biotinylation was then determined using Pierce 
Biotin Quantitation Kit (Thermo Scientific, USA). 
I. Conjugation of biotinylated IgG on dsDNA and SA 
Modified TurboBeads® 
28 µL of 4.2 µg/µL biotinylated human IgG was added into 
400 µL NPs solution prepared as in E. and F. (molar access of 
protein/DNA is 2:1). The mixture was then incubated in water 
bath sonicator for 1 h, followed by 3 washes with TE buffer. 
The NPs were then re-suspended in 400 µL of TE buffer. 10 µL 
of supernatant and 10 µL of well-suspended NPs mixture were 
taken for IgG analysis, respectively. 
J. DNA sample analysis 
DNA modified NPs were separated from 100 µL sample 
solution and re-suspended in 20 µL 5x SSC to yield a 5 times 
concentrated aliquot. The NPs were magnetically separated and 
10 µL of the supernatant was labeled as S1. The other 
un-separated DNA sample was labeled as S2. 3.3 µL of LDS 
sample buffer was added (Invitrogen, Australia) into S1 and S2 
and heated at 70°C over 10 min. NPs of S2 were separated from 
supernatant (10 µL) immediately after heating. 10 µL of S1 and 
S2 supernatant were loaded on NuPAGE® Novex 3-8% 
Tris-Acetate gel (Invitrogen, Australia) and stained with 
SYBR™ Safe DNA Gel Stain (Invitrogen, Australia) according 
to the manufacture’s instructions. 
K. Protein sample analysis 
 3.3 µL of LDS sample buffer (Invitrogen, Australia) was 
added to 10 µL of SA and IgG samples, followed by heating at 
70°C for 10 min. 10 µL supernatant was immediately taken 
after heating and  loaded on NuPAGE® Novex 4-12% Bis-Tris 
Gels (Invitrogen, Australia). The gel was stained with SYPRO® 
Ruby Protein Stain according to the manufacture’s instructions 
for protein analysis. 
III. RESULTS AND DISCUSSION 
A. DNA modification on Amine-coated TurboBeads® 
In this study, commercial cross-linkers, HydraLink™ 
(Sulfo-HyNic and Sulfo-4FB), were used as a pair to modify 
amine-coated TurboBeads® and Amine-GTTT ssDNA, 
respectively. Both Sulfo-HyNic and Sulfo-4FB contain 
N-hydroxysuccinimide ester (NHS), which could be attached to 
NPs and target ssDNA respectively by interacting with amine 
group and forming stable amide bonds. Modified magnetic NPs 
and ssDNA were purified via magnetic separation and DNA 
precipitation, respectively. After purification, modified ssDNA 
was attached to magnetic TurboBeads® via the formation of 
bis-aryl hydrazone bond between Sulfo-4FB and Sulfo-HyNic. 
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The complementary DNA, Bio-ACCC, was then added to form 
dsDNA on the NP’s surface (Fig. 1). The samples were 
analyzed on NuPAGE® Novex 3-8% Tris-Acetate gel. As a 
control, Sulfo-4FB modified Amine-GTTT was also 
hybridized with its complementary DNA, Bio-AAAC, in 5x 
SSC solution without NPs.  As shown in Fig .3, Lane 1, a band 
around 200bp was found on the gel, which confirmed the 
success of hybridization of Sulfo-4FB modified Amine-GTTT 
and Bio-AAAC without NPs. The same conditions were 
applied for DNA hybridization on the NPs’ surface. As showed 
in Fig. 3, the supernatant (Lane 2) was clear after intensive 
washing. On the other hand, , a band around 200 bp  was 
observed after heating the NPs with LDS buffer (Lane 3), 
which was target dsDNA released from NPs after heating with 
denaturing reagents. This result clearly confirmed the 
attachment of dsDNA on magnetic NPs via the covalent 
cross-linkers. 
 
 
Fig. 3 DNA assembly on amine-coated magnetic NPs. Lane 
description: lane L: 100 bp DNA Ladder. Lane 1: hybridization of 
Sulfo-4FB modified Amine-GTTT and Bio-AAAC without NPs. Lane 
2: supernatant of dsDNA modified magnetic NPs solution after 
washing. Lane 3: Mixture of homogeneous dsDNA modified magnetic 
NPs solution after washing. 
 
B. Antibody attachment on dsDNA modified amine-coated 
TurboBeads® 
 Before conjugating IgG to dsDNA modified NPs, 
biotinylation of IgG was performed. Accessible amino-groups 
of IgG were modified with Sulfo-NHS-biotin. The molar ratio 
of biotin to antibody was investigated using Pierce® Biotin 
Quantitation Kit. Based on measurements of UV absorbance, 5 
biotin molecules in average were successfully attached on each 
IgG molecule. 
In the next step, biotinylated IgG was conjugated to dsDNA 
modified magnetic NPs via biotin and SA interactions (Fig. 1). 
As mentioned above, the success of dsDNA assembly on 
magnetic NPs provided numerous biotin molecules on the 
surface of NPs, since single biotin molecule was synthesized on 
the end of complementary Bio-AAAC. The addition of SA 
specifically interacted with those biotin molecules and formed 
strong non-covalent bonds. SA is known to be a tetramer and 
each SA has four biotin binding sites. Thus, the attachment of 
SA on dsDNA provided abundant biotin binding sites on 
magnetic NPs’ surface, which enables attachment of 
biotinylated IgG in the final step. Homogeneous NPs solution, 
as well as NP-free supernatant from each step were collected 
and heated at 70°C for 10 min with LDS sample buffer. Under 
these conditions, SA was denatured from tetramer (MW= 52.8 
kDa) to monomer (MW=13.2 kDa), which also allowed 
conjugated SA and IgG to strip off from NPs and come into 
supernatant. As shown in Fig. 4, in the final step, there were 
two major bands, which respectively stood for IgG and SA, 
were seen in heated NPs sample solution (Lane 4) but not the 
supernatant without NPs (Lane 3). The results clearly confirm 
that both SA and IgG were successfully attached on magnetic 
NPs.  
 
 
Fig. 4 Antibody attachment on dsDNA modified amine-coated 
magnetic NPs. Lane description: Lane L, protein ladder 
(BenchMark™). Lane 1, the supernatant without NPs after SA 
addition. Lane 2, the supernatant with NPs after SA addition. Lane 3, 
the supernatant without NPs after SA and IgG addition. Lane 4, the 
supernatant with NPs after SA and IgG addition. Lane 5, SA. Lane 6, 
IgG.  
 
C. Biomolecular modification on SA-coated TurboBeads® 
 Another biomolecular modification strategy was completely 
developed via biotin-SA interaction, which is one of most 
common affinity interactions widely utilized in purification and 
detection system. In this study, Bio-AAAC (synthesized 
ssDNA with a biotin molecule at one of ends) was first 
assembled on SA-coated magnetic NPs. Since the 
complementary DNA, Bio-GTTT, also has a biotin molecule 
on its distal end, additional blocking step was conducted by 
using free biotin molecules to block unoccupied SA binding 
sites before the addition of complementary DNA. SA and 
biotinylated IgG were successively attached onto dsDNA 
modified NPs after the DNA hybridization step. As shown in 
Fig 5, no band was detected in lanes A2, B1, and B4, containing 
the NP-free supernatant after washing. However, after boiling 
the whole sample including the NPs, bands were appeared with 
the expected electrophoretic mobilities (Lane A3, B2, and B3). 
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The results convincingly showed that both dsDNA and target 
IgG had been successfully assembled on the surface of 
SA-coated magnetic NPs via biotin and SA specific 
interactions.  
 
Fig. 5 Biomolecular modification on SA modified magnetic NPs. A). 
Lane L: 100 bp DNA Ladder. Lane 1: hybridization of Bio-GTTT and 
Bio-AAAC in 5x SSC without NPs. Lane 2: supernatant of dsDNA 
modified TurboBeads® after washing. Lane 3: Mixture of 
homogeneous dsDNA modified TurboBeads® after heating. B). Lane 
L, protein ladder (BenchMark™). Lane 1, supernatant of mixture after 
SA addition. Lane 2, whole mixture including NPs after SA addition. 
Lane 3, whole mixture including NPs after SA and IgG addition. Lane 
4, supernatant of mixture after SA and IgG addition. Lane 5, SA. Lane 
6, IgG. 
 
IV. CONCLUSION 
In this work, two strategies were developed to conjugate 
biomolecules on the surface of magnetic NPs. Both amine- and 
SA-coated magnetic NPs were successfully modified. In one of 
methods, commercial cross-linkers, Sulfo-S-HyNic and 
Sulfo-S-4FB, were utilized to modify amine-coated NPs. 
Stable bis-aryl hydrazone bonds were formed and enabled 
controlled assembly of target DNA on NPs’ surface. The bonds 
formed between aromatic hydrazine (HyNic) and aromatic 
aldehyde is specific and offers stable and long shelf life. This 
covalent bond is stable for 2 hours at 94°C [17], which could 
prove highly usable in biomolecular conjugation studies. The 
other NPs modification method takes advantage of 
biotin-streptavidin interactions. The affinity of avidin to biotin 
is the strongest known non-covalent interactions between 
protein and ligand, which has also been successfully applied in 
NPs modification in this investigation. The results in this study 
confirmed that, via those two methods, the process of magnetic 
NPs modification with biomolecules could be well controlled. 
The target DNA and antibody were successfully attached on 
two different magnetic NPs, which offer potential for 
applications in more sophisticated nanoparticle-based 
assemblies. 
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